Obiectiv: Cancerul de sân este unul dintre cele mai devastatoare tipuri de cancer care afectează femeile. Pentru luarea deciziilor critice cu privire la soarta ţesutului mamar canceros, este necesară evaluarea implicării ganglionilor limfatici axilari (ALN). Cu toate acestea, o astfel de implicare ALN este dificil de prezis fără intervenţia chirurgicală. Prin urmare, un test uşor de predicţie care utilizează markeri de proteine poate fi o abordare dorită. În acest studiu, am efectuat o analiză completă a proteinomei pentru a descoperi modelul de exprimare a proteinelor legate de tumori în cancerul de sân primar. Metode şi Materiale: Proteinele au fost extrase din ţesuturile tumorale şi au fost supuse unei electroforeze în gel de poliacrilamidă în două dimensiuni (2D). Imaginile de gel rezultate au fost utilizate pentru compararea spoturilor inter-gel utilizând software-ul PDQuest Advance. Modelele obţinute au fost utilizate pentru diferenţierea tipurilor tumorale invazive de la cele neinvazive. Rezultate: 24 de pete de proteine conservate ale căror intensităţi au fost moderat reglementate înalt pe geluri. Aceste pete de proteine au fost folosite pentru a crea un model conservat 2D care acoperă un interval de pH de la 4 la 8. Concluzie: Punctele proteice care generează un model conservat între cancerul de sân primar şi ganglionul limfatic axilar au indicat că o abordare proteomică robustă şi foarte fiabilă, de exemplu 2DE, poate fi utilizată pentru a diferenţia forme metastatice de cancer de sân de la cele nemetastatice. 
Introduction
Breast cancer is the most commonly observed cause of cancer-related deaths among the women both in our country and around the world (1) . The metastasis of the disease to other tissues primarily occurs via the lymphatic system (2) . Cancer cells spread to the lymph nodes may then spread to distantly located organs e.g., lungs, liver and bones (3, 4) . Although there are various indicators of the spread of cancer cells, the lymph node metastasis is probably the most distinguished indicator and can be used to determine the stages of cancer, can give information about prognosis and be helpful in decision-making process about the possible therapies that is applied to the patients (5, 6) .
It has long been known that patients with Auxiliary Lymph Node (ALN) metastasis have worsened prognosis than the patients who do not have ALN. That is why the presence of ALN is still the most critical parameter in clinical decision making process. In more than several studies, it was demonstrated that ALN negative cases display better prognosis than ALN positive cases (8, 9) . These studies demonstrated that the number of metastatic lymph nodes is the determinant parameter for application of the adjuvant therapy (7, 10) . Despite the presence of these evidential data, there are ALN negative cases in which metastasis was present and ALN positive cases in which ten-year of survival without metastasis was observed (11, 12) . These observations led us question the reliability of ALN as the sole determinant of metastatic spread. Sentinel lymph node biopsy (SLNB) is considered to be an alternative to ALN dissection made for determination of ALN metastasis because ALN dissections are among the main reasons of morbidity. Yet, the observation of lymph node edema after SLNB raised the need for a less invasive method for evaluation of Auxiliary lymph nodes (13) .
In this study, we used 2D gel electrophoresis based proteomic approach to elucidate a pattern formed that may be useful in differentiation of metastatic BCs from non-metastatic BCs. Although this is preliminary study, it provided clues about the use of conventional proteomic approaches in differential diagnosis of BC.
Materials and Methods
The study was conducted at Kocaeli University Medical School DEKART Proteomics Laboratory, Turkey. Informed consents, approved by the institutional ethics committee, were obtained from each patient. Patients who received radio therapy or neo-adjuvant were not included in the study. We only included patients with pathologically confirmed ALN. All patients were followed at the Department of General Surgery and the tissue samples from ten ALN patients were used in this study. Tissues were removed and immediately snap-frozen in liquid nitrogen and stored at -80°C until use. The clinical and biochemical properties of the patient were summarized in Table 1 . Tissue samples were minced on ice and washed with ample amount of ice-cold phosphate buffer for three times to remove excess blood. After 10 min centrifugation at 4°C at 2000 ×g, the excess buffer was decanted and 100 μL of TPER buffer (Pierce Inc., USA) was added over each tissue pellet. To achieve complete lysis, the tissue pellets were vigorously vortexed using a Next Advance homogenizer with 1.6 mm stainless steel beads at +4ºC in 2DE rehydration buffer (8 M urea, 2 M thiourea, 4% CHAPS, 30 mM Tris pH 8.5, and 1 x protease inhibitor cocktail) and the supernatant containing the soluble protein fraction was obtained by centrifugation at 20.000 ×g for 30 min at 4°C. Protein concentration was determined by using modified Lowry assay with the BSA standard (BioRad, USA). The soluble protein containing supernatants were stored in Lo-bind tubes (Eppendorf, USA) at -80°C until analysis.
For the first-dimensional separation via isoelectric focusing (IEF), 550 μg from each protein sample was loaded onto immobilized pH gradient strips (IPG) (17 cm, pH 3-10, linear) via active rehydration (50 μA/IPG strip, at 20°C for 16 h). Isoelectric focusing was performed using Protean isoelectric focusing cell (BioRad, USA). The strips were run through a stepwise incremental voltage program [250 V for 30 min (linear), 4000 V for 2.5 hr (linear) and 40000 V/hr (rapid)]. The plate temperature was maintained at 20 °C. The strips were then subjected to a two-step equilibration in equilibration buffers containing 6M urea, 2% SDS, 0.375 M Tris-HCl pH 8.8, 20% glycerol and 2% DTT for the first step and the same buffer without DTT but with iodoacetamide (2.5%) for the second step with 20 min gentle shaking. Following equilibration steps, the IPG strips were rinsed with SDS-PAGE running buffer and loaded directly onto 1 mm-thick 12% in-house made SDS-polyacrylamide gels. The second dimension was accomplished by using Dodeca gel running system (BioRad, USA) to minimize gel to gel variation. Electrophoresis was carried out at 16ºC at 45 mA/gel until the front dye reached the bottom of the gels. The gels were fixed for six hours (10% acetic acid, 40% methanol) and stained with SYPRO Ruby (BioRad, USA). Triplicate gels were produced for each sample.
The gel images were taken with VersaDoc 4000MP (BioRad, USA) and analyzed by using PDQuest Advance 2D image analysis software (Bio Rad, USA). The quality of each spot was normalized using local regression model. Based on average spot volume ratio, spots whose relative expression levels were changed ar least 2-fold (increase or decrese) among the compared groups were considered to be significant.
Results
As listed in Table 1 , female cancer patients who are at stages 5-3a and 1-2b) were accepted to this study. All cases were determined to be grade II and hormone receptor positive in their histopathological examinations. Except case II, all cases were in their postmenopausal stages. Tissue samples and lymph nodes were used to prepare protein extracts and the protein extracts were used to produce wellresolved high resolution 2D gels. Automated analysis of the stained 2D gels revealed the presence of 750±50 protein spots. However, visual inspection and manual editing of the gels revealed that some of the protein spots detected by automated spot analysis tool were ambiguous and could not be matched even within the groups (Fig. 1A and B) . To overcome this problem, master gels were created for each group by matching the protein spots that were present in each member of the groups. The master gels were then used to perform inter-group comparisons (Fig. 1C) . Conserved spots were determined between the groups and these spots were used to generate a conserved spot profile. There were 24 conserved spots whose intensities were moderately high on the gels. They were consisted of mostly high molecular weight proteins spanning a pH range of 4 to 8.
Discussion
Stages of tumor have been determined by the help of physical examination, biopsy and the use of various imaging technologies. Determination of the type of therapy that will be used for treatment is highly important for the prognosis of the disease. Cells detach from some breast tumor tissues may initially indwell into the axillary lymph nodes (14) . On the other hand, some other breast tumor cells do not prefer to settle into to the lymph nodes before metastasize. The reason behind this interesting phenomenon is not known. In this study, we wished to test if we can predict ALN metastasis in breast cancer patients at a preoperative stage by performing comparative proteome analysis. There is evidence suggesting that the molecular events dictating distant organ metastasis are somewhat different then ALN metastasis (13) . In a study using microarray technology, researchers demonstrated that gene expression profiles of cells from primary cancer tissues and ALNs share high similarities (13) . However, other studies demonstrated otherwise claiming that metastasized cells in the ALNs display major differences than their primary look-alikes at the molecular level (15) (16) (17) (18) . There are studies investigated breast tumor tissues and their ALNs to which tumor was metastasized. Those studies mainly demonstrated the similarities between the tumor tissues and the ALNs using histopathological examinations. The phenotypic similarities revealed in these studies were also confirmed in transcriptomic studies (15, (19) (20) (21) . On the other hand, studies focused on chromosomal abnormalities among the primary breast tumor tissues and their respective ALNs showed some ALN (B) tissue samples. The twenty four spots (C), that obtained from comparison of the master gels, may help explain the mechanism behind the spread of breast cancer to the lymph node noteworthy differences (13, 22) . In overall, a consensus cannot be reached among the studies regarding the similarities and the differences between the primary tumor tissues and their respective ALNs. An conventional approach was utilized by Lee et al. to provide evidence at the molecular level for differentiation of primary tumor tissues from their respective ALNs to which tumor cells were metastasized. The researchers used 2D gel electrophoresis to evaluate tumor samples at different stages (NO, N1, N2). They detected 12 down-regulated and an upregulated protein spots. Subsequent LC-MS/MS analysis to identify those proteins indicated that calretuculin and tropomyocine alpha were regulated in all studied tumor samples (NO, N1 and N2) in comparison to the healthy controls. In addition, the researchers proposed several potential biomarkers that may be useful for differentiation of the cancer stages. Those biomarker candidates included Hsp70 for NO, 80kDa protein H precursor and protein disulfide isomerase (PDI) for N1 and 78 kDA glucose regulated protein for N2 (23) .
In this study, to differentiate primary tumors that metastasize to ALN from the primary tumors that do not metastasize to ALN, we used a 2D based approach. We hypothesized that elucidating a proteome profile between the tumor tissues and their respective ALNs should help elucidation of proteins involving to the process of metastatic transition. We also predicted that the changes observed in the levels of these proteins might also indicate thei level of their involvement to metastasis. The assumption was also made that the spots that could not be matched among the tumor samples and ALN samples or between the tumor samples and their respective ALNs might originate from individual sample complexities that are commonly observed when human samples are used (24) . The inner and inter group spot matching efforts revealed the presence of 24 protein spots. These 24 all-matching spots displayed a unique proteome pattern spanning a pH range of 4 to 8 between the molecular weight ranges of 40000 to 120000 Da. These spots are needed to be identified to obtain further clues about their roles in induction of metastasis from primary tumor tissue to nearby lymph nodes. The changes in abundance of these proteins may reflect their contribution to the rate of metastatic process.
Conclusion
In conclusion, this study placed an emphasis on the all-matching protein spots between primary tumor tissues and their respective ALNs and provided a proposition that a 2D gel electrophoresis pattern between pH ranges of 4 to 8 may be useful for predicting the metastatic process. Although initial, the results presented here demonstrated by using a multivariate approach in which evolving patterns involving more than several proteins might be used for differentiation of invasive tumor types from non-invasive ones.
